Vertex Pharmaceuticals IncorporatedVRTXNASDAQ
Loading
Book Value/Share Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-27.8%
5Y CAGR-18.7%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-27.8%/yr
vs -23.5%/yr prior
5Y CAGR
-18.7%/yr
Recent deceleration
Acceleration
-4.3pp
Decelerating
Percentile
P29
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 14.55% |
| 2024 | -6.59% |
| 2023 | 25.58% |
| 2022 | 38.61% |
| 2021 | 17.23% |
| 2020 | 41.04% |
| 2019 | 35.90% |
| 2018 | 112.53% |
| 2017 | 49.72% |
| 2016 | 20.88% |